<p>Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has announced the issuance of 47,500,000 new A Shares at an issue price of RMB26.68 per share. The A Shares will be listed on the STAR Market of the Shanghai Stock Exchange. The offer price was determined through preliminary price consultations, considering company fundamentals, market conditions, industry valuations, capital requirements, and underwriting risks. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biocytogen Pharmaceuticals Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251127-11929756), on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

688796

<p>Biocytogen Pharmaceuticals Beijing Co., Ltd. announced an IPO of 47.5 million A Shares at RMB26.68 per share on the STAR Market, Shanghai Stock Exchange. The offer price was set after preliminary consultations, considering various factors. The news was generated by Public Technologies using AI and is for informational purposes only.</p>

Biocytogen Pharmaceuticals Beijing Announces A Share IPO on STAR Market